We are a game changer

It’s easier to get things done at Mizzou

Partnering with the University of Missouri in Columbia will help you leverage your investment of time and money for more tangible results. You will have access to the largest public research university in the state with its one-of-a-kind programs and top-tier students, faculty and staff.

Your competitive advantage

Connect with a research powerhouse

MU offers a rare blend of expertise and resources, including medicine, veterinary medicine, agriculture and engineering on the same campus along with the most powerful university research reactor in America. Our NextGen Precision Health initiative, which unites private partners with MU’s network of hospitals, clinics and extension programs, is poised to accelerate medical breakthroughs for patients in Missouri and beyond.

NextGen building exterior

Let's Work Together

Sponsor research

We can help you turn your ideas into reality. Work with MU faculty consultants or partner with them on joint research projects.

License our innovations

With more than 100 new inventions every year, our portfolio of technologies is ready to be further developed for the marketplace, where research truly benefits society.

Access equipment & expertise

MU’s electron microscopy core research facility developed with Thermo Fischer Scientific and other advanced technology cores offer services and specialized equipment on a fee-for-service basis.

Incubate your business

Grow your business or invest in a new one located at the MU Life Science Business Incubator and numerous university research parks.

Develop your workforce

Gain a competitive edge by attracting talented MU interns and graduates.

Conduct clinical research

Hold your Phase I clinical trial at MU. Each year, we run hundreds of trials to test medical treatments for humans and animals.

Your Contacts

Roy Hartline

Roy Hartline

Executive Director of Industry Partnerships and Engagement

Megan Jahnsen

Megan Jahnsen

Research Proposal Development Lead

Our Partners

Okan Ekinci, Senior Vice President and Global Head of Marketing and Innovation

Roche Information Solutions

"MU Health Care established a high level of ‘clinical agility’ that allowed us to jointly explore, implement and evaluate digital health products in iterative cycles. Collaborating with the experts at MU keeps our teams always close to the real-world needs and challenges of clinicians and patients."

More about our partners
Okan Ekinci




Active industry partners

$98.8 million

In industry-sponsored research


Option and license agreements signed by companies to use MU innovations

Staff working at MURR

The MU Research Reactor has an exclusive agreement with Advanced Accelerator Applications International, SA (AAA), a Novartis company, to provide a key ingredient in a cancer therapy.

Girl taking a hearing test

The FDA recently approved a pediatric clinical trial to test a new gene therapy developed by Decibel Therapeutics with MU patented technology to restore hearing.  

photo of members of the tumor board

The School of Medicine and Roche developed NAVIFY tumor board software to streamline crucial information and data for clinician teams providing personalized care to cancer patients.

More opportunities

MU increasingly relies on private philanthropy to provide the “margin of excellence,” including investment from corporate and foundation partners. Contact Mizzou Advancement’s Corporate Relations team to discuss your priorities and explore opportunities.